Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials
- PMID: 15286056
- PMCID: PMC506853
- DOI: 10.1136/bmj.38159.639028.7C
Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials
Abstract
Objective: To assess the efficacy of topical non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of osteoarthritis.
Data sources: Medline, Embase, Scientific Citation Index, CINAHL, Cochrane Library, and abstracts from conferences.
Review methods: Inclusion criterion was randomised controlled trials comparing topical NSAIDs with placebo or oral NSAIDs in osteoarthritis. Effect size was calculated for pain, function, and stiffness. Rate ratio was calculated for dichotomous data such as clinical response rate and adverse event rate. Number needed to treat to obtain the clinical response was estimated. Quality of trial was assessed, and sensitivity analyses were undertaken.
Results: Topical NSAIDs were superior to placebo in relieving pain due to osteoarthritis only in the first two weeks of treatment. Effect sizes for weeks 1 and 2 were 0.41 (95% confidence interval, 0.16 to 0.66) and 0.40 (0.15 to 0.65), respectively. No benefit was observed over placebo in weeks 3 and 4. A similar pattern was observed for function, stiffness, and clinical response rate ratio and number needed to treat. Topical NSAIDs were inferior to oral NSAIDs in the first week of treatment and associated with more local side effects such as rash, itch, or burning (rate ratio 5.29, 1.14 to 24.51).
Conclusion: Randomised controlled trials of short duration only (less than four weeks) have assessed the efficacy of topical NSAIDs in osteoarthritis. After two weeks there was no evidence of efficacy superior to placebo. No trial data support the long term use of topical NSAIDs in osteoarthritis.
Figures
Comment in
-
Review: topical NSAIDs reduce pain in osteoarthritis only during the first 2 weeks of use.Evid Based Nurs. 2005 Jan;8(1):20-1. doi: 10.1136/ebn.8.1.20. Evid Based Nurs. 2005. PMID: 15688494 No abstract available.
Similar articles
-
Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.Cochrane Database Syst Rev. 2002;(2):CD003686. doi: 10.1002/14651858.CD003686. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2013 May 31;(5):CD003686. doi: 10.1002/14651858.CD003686.pub2. PMID: 12076503 Updated. Review.
-
Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data.Ophthalmic Epidemiol. 2007 Sep-Oct;14(5):311-9. doi: 10.1080/09286580701299411. Ophthalmic Epidemiol. 2007. PMID: 17994441
-
Topical nonsteroidal anti-inflammatory drugs for osteoarthritis.Postgrad Med. 2010 Nov;122(6):98-106. doi: 10.3810/pgm.2010.11.2227. Postgrad Med. 2010. PMID: 21084786 Review.
-
Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies.Br J Sports Med. 2018 May;52(10):642-650. doi: 10.1136/bjsports-2017-098043. Epub 2018 Feb 7. Br J Sports Med. 2018. PMID: 29436380 Free PMC article. Review.
-
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.BMJ. 2021 Oct 12;375:n2321. doi: 10.1136/bmj.n2321. BMJ. 2021. PMID: 34642179 Free PMC article.
Cited by
-
Amentoflavone maintaining extracellular matrix homeostasis and inhibiting subchondral bone loss in osteoarthritis by inhibiting ERK, JNK and NF-κB signaling pathways.J Orthop Surg Res. 2024 Oct 15;19(1):662. doi: 10.1186/s13018-024-05075-2. J Orthop Surg Res. 2024. PMID: 39407273 Free PMC article.
-
Efficacy of S-Flurbiprofen Plaster for Analgesia Following Total Hip Arthroplasty.Cureus. 2024 Aug 13;16(8):e66805. doi: 10.7759/cureus.66805. eCollection 2024 Aug. Cureus. 2024. PMID: 39280551 Free PMC article.
-
Cartilage progenitor cells derived extracellular vesicles-based cell-free strategy for osteoarthritis treatment by efficient inflammation inhibition and extracellular matrix homeostasis restoration.J Nanobiotechnology. 2024 Jun 19;22(1):345. doi: 10.1186/s12951-024-02632-z. J Nanobiotechnology. 2024. PMID: 38890638 Free PMC article.
-
Evidence-Based Review of Nonsurgical Treatments for Knee and Hip Osteoarthritis.Eur J Rheumatol. 2024 Mar 25;11(Suppl 1):S48-52. doi: 10.5152/eurjrheum.2024.22096. Online ahead of print. Eur J Rheumatol. 2024. PMID: 38705970 Free PMC article.
-
Enhancing the Topical Antibacterial Activity of Fusidic Acid via Embedding into Cinnamon Oil Nano-Lipid Carrier.Gels. 2024 Apr 16;10(4):268. doi: 10.3390/gels10040268. Gels. 2024. PMID: 38667687 Free PMC article.
References
-
- Felson DT. Epidemiology of hip and knee osteoartritis. Epidemiol Rev 1988;10: 1-28. - PubMed
-
- Yelin E. The earnings, income, and assets of persons aged 51-61 with and without musculoskeletal conditions. J Rheumatol 1997;24: 2024-30. - PubMed
-
- Wynne HA, Campell M. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs). Pharmacoeconomics 1994;3: 107-23. - PubMed
-
- Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000;95: 1681-90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials